The Filing Desk

InfuSystem vs Neuronetics

InfuSystem INFU · Neuronetics STIM · Health Care Equipment

Neuronetics reported revenue of $149 million in fiscal 2025, about the same as InfuSystem's $143 million in fiscal 2025. InfuSystem's revenue grew 6.4% in its latest year, and Neuronetics' grew 99.2%. InfuSystem had an operating margin of 8.3%, against -21.1% at Neuronetics. Free cash flow was $24 million at InfuSystem and −$21 million at Neuronetics.

Side by side

InfuSystemNeuronetics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$143M$149M
Revenue growth6.4%99.2%
Revenue growth a year, last 5 years8.0%24.8%
Gross margin56.0%48.5%
Operating margin8.3%−21.1%
Net margin4.6%−26.1%
Free cash flow$24M−$21M
Free cash flow margin16.6%−14.2%
Return on capital9.6%−37.5%
Net debt to EBITDA0.7x—
Dividends and buybacks$10M$0M
Change in diluted share count−2.8%107.8%
Last close$14.06$1.24
P/E at the last close32.0×—
Insider trades, last 12 monthsbought $150,396, sold $0bought $4.8 million, sold $270,405
Piotroski F-score8 of 94 of 9
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
InfuSystemNeuronetics
Operating margin
Percent of revenue
InfuSystemNeuronetics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
InfuSystemNeuronetics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the InfuSystem and Neuronetics pages.